Alnylam Pharmaceuticals Inc (ALNY)
NASDAQ · Healthcare
Alnylam Pharmaceuticals Inc Cash Flow 2008–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||
| Operating Cash Flow | 524.1M | -8.3M | 104.2M | -541.3M | -641.7M | -615.0M | -278.4M | -562.6M | -382.8M | -307.7M | -68.7M | -115.6M | -87.1M | -84.3M | -72.1M | 65.5M |
| Depreciation & Amort. | 55.7M | 56.7M | 54.1M | 44.5M | 47.6M | 34.8M | 17.2M | 15.2M | 13.4M | 15.1M | 10.2M | 9.0M | 5.1M | 4.9M | 6.0M | 5.7M |
| Investing Activities | ||||||||||||||||
| Capital Expenditure | 58.7M | 34.3M | 62.2M | 72.1M | 76.4M | 70.4M | 140.2M | 126.9M | 104.2M | 64.6M | 4.0M | 8.3M | 1.3M | 4.7M | 4.9M | 10.8M |
| Free Cash Flow | 465.4M | -42.6M | 41.9M | -613.3M | -718.1M | -685.3M | -418.6M | -689.5M | -487.0M | -372.3M | -72.7M | -124.0M | -88.4M | -89.1M | -77.1M | 54.7M |
| Financing Activities | ||||||||||||||||
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Alnylam Pharmaceuticals Inc Cash Flow — FAQ
Alnylam Pharmaceuticals Inc (ALNY) cash flow over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALNY's cash flow history?
The chart and table above show Alnylam Pharmaceuticals Inc's cash flow by year and by quarter, including the growth rate.